Directors Dealings
According to Art. 19 Para. 1 Sentence 1 MAR, persons who perform managerial tasks at an issuer or persons who are closely related to them must notify the issuer and BaFin of their own transactions in financial instruments of the issuer or related financial instruments without delay and no later than three business days after the date of the transaction.
28.02.2023 | Directors-Dealings-Notification
Mr. Christian Frick, CEO of Geratherm Medical AG, informs that Dr. Frank (Chairman of the Supervisory Board) bought Geratherm Medical AG shares via Xetra at a price of EUR 7.87 per share with a total volume of EUR 46.984,51.
Read the full publication on EQS-News.
__________________________
10.02.2023 | Directors-Dealings-Notification
Mr. Christian Frick, CEO of Geratherm Medical AG, informs that Dr. Frank (Chairman of the Supervisory Board) bought Geratherm Medical AG shares via Xetra at a price of EUR 6.26 per share with a total volume of EUR 50,563.92.
Read the full publication on EQS-News.
__________________________
27.01.2023 | Directors-Dealings-Notification
Mr. Christian Frick, CEO of Geratherm Medical AG, informs that Dr. Frank (Chairman of the Supervisory Board) bought Geratherm Medical AG shares via Xetra at a price of EUR 5.90 per share with a total volume of EUR 29,500.00.
Read the full publication on EQS-News.
01.09.2022 | Directors-Dealings-Notification
Mr. Christian Frick, CEO of Geratherm Medical AG, informs that Dr. Frank (Chairman of the Supervisory Board) purchased shares of Geratherm Medical AG via Xetra at a price of 7.35 EUR/piece with a total volume of 45,443.10 EUR.
Read the complete publication.
__________________________
31.08.2022 | Directors-Dealings-Notification
Mr. Christian Frick, Member of the Executive Board of Geratherm Medical AG, announces that he has purchased shares of Geratherm Medical AG via Xetra at a price of 7.29 EUR/piece with a total volume: of 14,580.00 EUR.
Read the complete publication.
__________________________
11.05.2022 | Directors-Dealings-Notification
The Executive Board of Geratherm Medical AG hereby announces that pursuant to Section 43 (1) of the German Securities Trading Act (WpHG), due to exceeding the threshold of 10% of the voting rights of Geratherm Medical AG, the objectives pursued with the acquisition of the voting rights and the origin of the funds used for the acquisition are as follows.
For the objectives pursued by the acquisition, see here Publication pursuant to Sec. 40 (1) WpHG
__________________________
28.04.2022 | Directors-Dealings-Notification
The Executive Board of Geratherm Medical AG has announced that on April 28, 2022, the acquisition or sale of shares with voting rights and a change in the total number of voting rights took place.
Read the complete publication pursuant to section 40 (1) WpHG.
__________________________
27.04.2022 | Directors-Dealings-Notification
Read the complete publication according to § 40 WpHG
__________________________
21.04.2022 | Directors-Dealings-Notification
Read the complete publication according to § 40 WpHG
__________________________
14.04.2022 | Directors-Dealings-Notification
Read the complete publication of the total number of voting rights according to section 41 WpHG with the aim of a Europe-wide distribution
23.06.2016 | Directors-Dealings-Notification
Dr. Gert Frank, member of the Executive Board of Geratherm Medical AG, has informed us that he sold 60,000 shares of Geratherm Medical AG off-market on April 2, 2020 at a price of 11.10 euros/piece (total volume: 666,000.00 EUR).
Read the full publication.
18.01.2017 | Directors-Dealings-Notification
The Executive Board of Geratherm Medical AG has announced that on January 18, 2017, the acquisition or sale of shares with voting rights and a change in the total number of voting rights took place.
23. Juni 2016 | Directors-Dealings-Notification
Dr. Gert Frank, Member of the Executive Board of Geratherm Medical AG, has informed us that he sold 20,000 shares of Geratherm Medical AG off-market on June 22, 2016 at a price of 11.50 euros/piece (total volume: 230,000.00 EUR).
__________________________
05. April 2016 | Directors-Dealings-Notification
Dr. Gert Frank, member of the Executive Board of Geratherm Medical AG, has informed us that he sold 50,000 shares of Geratherm Medical AG at a price of 11.50 euros/piece (total volume: 575,000.00 EUR) via Xetra from March 31 to April 4.
24.07.2015 | Directors-Dealings-Notification
Dr. Gert Frank, Chairman of the Executive Board of Geratherm Medical AG, has informed us that he sold 20,000 shares of Geratherm Medical AG via Xetra on July 23, 2015 at a price of 12.25 euros/piece (total volume: EUR 245,000.00).
__________________________
20.07.2015 | Directors-Dealings-Notification
Dr. Gert Frank, Chairman of the Executive Board of Geratherm Medical AG, has informed us that he sold 30,000 shares of Geratherm Medical AG via Xetra on July 16, 2015 at a price of 12.25 euros per share (total volume: EUR 367,500.00).
__________________________
15.03.2010 | Directors-Dealings-Notification
Dr. Gert Frank, Chairman of the Executive Board of Geratherm Medical AG, has informed us that he sold 100,000 shares of Geratherm Medical AG off-market on March 11, 2010 at a price of 8.00 euros per share (total volume: 800,000.00 euros).
__________________________
10. 02.2010 | Directors-Dealings-Notification
Dr. Gert Frank, Chairman of the Executive Board of Geratherm Medical AG, has informed us that he sold 19,000 shares of Geratherm Medical AG off-market on February 10, 2010 (date of transaction) at a price of 7.35 euros per share (total volume: 139,650 euros).
__________________________
12.01.2010 | Directors-Dealings-Notification
Dr. Gert Frank, Chairman of the Executive Board of Geratherm Medical AG, has informed us that he sold 10,000 shares of Geratherm Medical AG off-market on January 11, 2010 (date of transaction) at a price of 7.32 euros per share (total volume: 73,200 euros).